Advanced Clinical Decision Support Platforms Market By Type (Therapeutic, Diagnostic), By Model (Knowledge based, Non Knowledge based), By Setting (Hospitals, Ambulatory care): Global Opportunity Analysis and Industry Forecast, 2021-2031
The Advanced Clinical Decision Support Platforms Market valued for $496.4 million in 2021 and is estimated to reach $1,175.0 million by 2031, exhibiting a CAGR of 9.0% from 2022 to 2031. Advanced clinical decision support platforms or computerized clinical decision support systems (CDSS) represent a paradigm shift in healthcare sector. CDSS are used to augment clinicians in their complex decision-making processes. It is a type of system that offers health information technology to doctors, staff, patients, and other individuals with knowledge and person-specific information that are intelligently filtered or provided at the right moment to enhance health and health care. Clinical decision support systems are core component of electronic health records. These tools can alert the physician about potential errors, remind them to provide preventive care, help them to make diagnosis, and assist with treatment.
The growth of advanced clinical decision support platforms market is driven by technological advancement in the development of different clinical decision support systems and increase in number of various strategies adopted such as product launch and product approval by the key market players. In addition, rise in government initiatives for promoting digital healthcare boosts the market growth. Governments across the world are increasingly taking steps to promote digital health and the use of advanced clinical decision support systems. Thus, this factor is attributed to drive the demand for advanced clinical decision support systems and fuel the growth of market.
Moreover, there is rise in the prevalence of chronic diseases such as diabetes, cancer, and cardiovascular diseases, which drives the demand for advanced clinical decision support systems, as these systems help healthcare professionals to provide better care for such conditions. Clinical decision support systems (CDSSs) can help clinicians to assess cardiovascular disease (CVD) risk & manage CVD risk factors by providing tailored assessments and treatment recommendations based on individual patient data. As Cardiovascular disease is the term for all types of diseases that affect the heart or blood vessels, including coronary heart disease, which can cause heart attacks, stroke, congenital heart defects, therefore, clinical decision support system can also be useful in treatment of coronary heart disease.
Thus, rise in prevalence of coronary heart disease fosters the demand for advanced clinical decision support system by physicians and fuels the growth of market. For instance, according to report shared by Center for Disease Control and Prevention (CDC), it was reported that, coronary heart disease is the most common type of heart disease, killing 382,820 people in the U.S. in 2020. Moreover, in 2020, about 2 in 10 deaths from coronary artery disease (CAD) were in adults less than 65 years old.
Clinical decision support systems are often integrated into telemedicine clinical practice. Thus, rise in usage of telemedicine platform by physician contributes to the growth of market. For instance, according to Centers for Disease Control and Prevention (CDC) in December 2022, it was reported that, from 2019 to 2021, the use of telemedicine technology increased for office-based physicians from 15.4% to 85.9%. In both 2019 and 2021, the use of telemedicine technology was higher among primary care physicians and medical specialty physicians On the other hand, high cost of electronic health record systems and cyber security issues associated with advanced clinical decision support platforms are some factors that are anticipated to restrain the growth of the advanced clinical decision support platforms market.
The advanced clinical decision support platforms market is segmented into type, model, setting, and region. By type, the market is bifurcated into therapeutic and diagnostic. The diagnostic segment is further bifurcated into hospitals and ambulatory care. Therapeutic segment is further subdivided into hospitals and ambulatory care. By model, the market is divided into knowledge based and non-knowledge based. By setting, the market is classified into hospital and ambulatory care.
Region-wise; the market is analyzed across North America (U.S., Canada, Mexico), Europe (Germany, France, UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, India, Australia, South Korea, and rest of Asia Pacific), and LAMEA (Brazil, Saudi Arabia, South Africa, and rest of LAMEA). Some of the major companies that operate in the global advanced clinical decision support platforms market include Siemens Healthineers, Wolters Kluwer, Zynx Health, Oracle Corporation, IBM Watson Health, NextGen Healthcare Inc., Veradigm Inc., Meditech, Epic Systems Corporation, and Elsevier B.V.
Key Benefits For Stakeholders
This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the advanced clinical decision support platforms market analysis from 2021 to 2031 to identify the prevailing advanced clinical decision support platforms market opportunities.
The market research is offered along with information related to key drivers, restraints, and opportunities.
Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
In-depth analysis of the advanced clinical decision support platforms market segmentation assists to determine the prevailing market opportunities.
Major countries in each region are mapped according to their revenue contribution to the global market.
Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
The report includes the analysis of the regional as well as global advanced clinical decision support platforms market trends, key players, market segments, application areas, and market growth strategies.
Key Market Segments
By Model
Knowledge based
Non Knowledge based
By Setting
Ambulatory care
Hospitals
By Type
Therapeutic
Setting
Hospitals
Ambulatory care
Diagnostic
Setting
Hospitals
Ambulatory care
By Region
North America
U.S.
Canada
Mexico
Europe
Germany
France
UK
Italy
Spain
Rest of Europe
Asia-Pacific
Japan
China
India
Australia
South Korea
Rest of Asia-Pacific
LAMEA
Brazil
Saudi Arabia
South Africa
Rest of LAMEA
Key Market Players
Oracle Corporation
Wolters Kluwer
Meditech
IBM Watson Health
Veradigm Inc.
Epic Systems Corporation
NextGen Healthcare Inc.
Zynx health
Siemens Healthineers
Relx Group
Please Note: It will take 7-10 business days to complete the report upon order confirmation.
- CHAPTER 1: INTRODUCTION
- 1.1. Report description
- 1.2. Key market segments
- 1.3. Key benefits to the stakeholders
- 1.4. Research Methodology
- 1.4.1. Primary research
- 1.4.2. Secondary research
- 1.4.3. Analyst tools and models
- CHAPTER 2: EXECUTIVE SUMMARY
- 2.1. CXO Perspective
- CHAPTER 3: MARKET OVERVIEW
- 3.1. Market definition and scope
- 3.2. Key findings
- 3.2.1. Top impacting factors
- 3.2.2. Top investment pockets
- 3.3. Porter’s five forces analysis
- 3.3.1. Bargaining power of suppliers
- 3.3.2. Bargaining power of buyers
- 3.3.3. Threat of substitutes
- 3.3.4. Threat of new entrants
- 3.3.5. Intensity of rivalry
- 3.4. Market dynamics
- 3.4.1. Drivers
- 3.4.1.1. Growth in incidence of medication error
- 3.4.1.2. Increase in application of electronic health record system
- 3.4.1.3. Rise in geriatric population and increase in prevalence of chronic diseases
- 3.4.2. Restraints
- 3.4.2.1. Data security concerns related to cloud based CDSS
- 3.4.2.2. Increase in the incidence of data breach
- 3.4.3. Opportunities
- 3.4.3.1. Increase in number of adoptions of key strategies for development of market
- 3.5. COVID-19 Impact Analysis on the market
- CHAPTER 4: ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY TYPE
- 4.1. Overview
- 4.1.1. Market size and forecast
- 4.2. Therapeutic
- 4.2.1. Key market trends, growth factors and opportunities
- 4.2.2. Market size and forecast, by region
- 4.2.3. Market share analysis by country
- 4.2.4. Therapeutic Advanced Clinical Decision Support Platforms Market by Setting
- 4.2.4.1. Hospitals Market size and forecast, by region
- 4.2.4.2. Ambulatory care Market size and forecast, by region
- 4.3. Diagnostic
- 4.3.1. Key market trends, growth factors and opportunities
- 4.3.2. Market size and forecast, by region
- 4.3.3. Market share analysis by country
- 4.3.4. Diagnostic Advanced Clinical Decision Support Platforms Market by Setting
- 4.3.4.1. Hospitals Market size and forecast, by region
- 4.3.4.2. Ambulatory care Market size and forecast, by region
- CHAPTER 5: ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY MODEL
- 5.1. Overview
- 5.1.1. Market size and forecast
- 5.2. Knowledge based
- 5.2.1. Key market trends, growth factors and opportunities
- 5.2.2. Market size and forecast, by region
- 5.2.3. Market share analysis by country
- 5.3. Non Knowledge based
- 5.3.1. Key market trends, growth factors and opportunities
- 5.3.2. Market size and forecast, by region
- 5.3.3. Market share analysis by country
- CHAPTER 6: ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY SETTING
- 6.1. Overview
- 6.1.1. Market size and forecast
- 6.2. Hospitals
- 6.2.1. Key market trends, growth factors and opportunities
- 6.2.2. Market size and forecast, by region
- 6.2.3. Market share analysis by country
- 6.3. Ambulatory care
- 6.3.1. Key market trends, growth factors and opportunities
- 6.3.2. Market size and forecast, by region
- 6.3.3. Market share analysis by country
- CHAPTER 7: ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY REGION
- 7.1. Overview
- 7.1.1. Market size and forecast By Region
- 7.2. North America
- 7.2.1. Key trends and opportunities
- 7.2.2. Market size and forecast, by Type
- 7.2.2.1. North America Therapeutic Advanced Clinical Decision Support Platforms Market by Setting
- 7.2.2.2. North America Diagnostic Advanced Clinical Decision Support Platforms Market by Setting
- 7.2.3. Market size and forecast, by Model
- 7.2.4. Market size and forecast, by Setting
- 7.2.5. Market size and forecast, by country
- 7.2.5.1. U.S.
- 7.2.5.1.1. Key market trends, growth factors and opportunities
- 7.2.5.1.2. Market size and forecast, by Type
- 7.2.5.1.3. Market size and forecast, by Model
- 7.2.5.1.4. Market size and forecast, by Setting
- 7.2.5.2. Canada
- 7.2.5.2.1. Key market trends, growth factors and opportunities
- 7.2.5.2.2. Market size and forecast, by Type
- 7.2.5.2.3. Market size and forecast, by Model
- 7.2.5.2.4. Market size and forecast, by Setting
- 7.2.5.3. Mexico
- 7.2.5.3.1. Key market trends, growth factors and opportunities
- 7.2.5.3.2. Market size and forecast, by Type
- 7.2.5.3.3. Market size and forecast, by Model
- 7.2.5.3.4. Market size and forecast, by Setting
- 7.3. Europe
- 7.3.1. Key trends and opportunities
- 7.3.2. Market size and forecast, by Type
- 7.3.2.1. Europe Therapeutic Advanced Clinical Decision Support Platforms Market by Setting
- 7.3.2.2. Europe Diagnostic Advanced Clinical Decision Support Platforms Market by Setting
- 7.3.3. Market size and forecast, by Model
- 7.3.4. Market size and forecast, by Setting
- 7.3.5. Market size and forecast, by country
- 7.3.5.1. Germany
- 7.3.5.1.1. Key market trends, growth factors and opportunities
- 7.3.5.1.2. Market size and forecast, by Type
- 7.3.5.1.3. Market size and forecast, by Model
- 7.3.5.1.4. Market size and forecast, by Setting
- 7.3.5.2. France
- 7.3.5.2.1. Key market trends, growth factors and opportunities
- 7.3.5.2.2. Market size and forecast, by Type
- 7.3.5.2.3. Market size and forecast, by Model
- 7.3.5.2.4. Market size and forecast, by Setting
- 7.3.5.3. UK
- 7.3.5.3.1. Key market trends, growth factors and opportunities
- 7.3.5.3.2. Market size and forecast, by Type
- 7.3.5.3.3. Market size and forecast, by Model
- 7.3.5.3.4. Market size and forecast, by Setting
- 7.3.5.4. Italy
- 7.3.5.4.1. Key market trends, growth factors and opportunities
- 7.3.5.4.2. Market size and forecast, by Type
- 7.3.5.4.3. Market size and forecast, by Model
- 7.3.5.4.4. Market size and forecast, by Setting
- 7.3.5.5. Spain
- 7.3.5.5.1. Key market trends, growth factors and opportunities
- 7.3.5.5.2. Market size and forecast, by Type
- 7.3.5.5.3. Market size and forecast, by Model
- 7.3.5.5.4. Market size and forecast, by Setting
- 7.3.5.6. Rest of Europe
- 7.3.5.6.1. Key market trends, growth factors and opportunities
- 7.3.5.6.2. Market size and forecast, by Type
- 7.3.5.6.3. Market size and forecast, by Model
- 7.3.5.6.4. Market size and forecast, by Setting
- 7.4. Asia-Pacific
- 7.4.1. Key trends and opportunities
- 7.4.2. Market size and forecast, by Type
- 7.4.2.1. Asia-Pacific Therapeutic Advanced Clinical Decision Support Platforms Market by Setting
- 7.4.2.2. Asia-Pacific Diagnostic Advanced Clinical Decision Support Platforms Market by Setting
- 7.4.3. Market size and forecast, by Model
- 7.4.4. Market size and forecast, by Setting
- 7.4.5. Market size and forecast, by country
- 7.4.5.1. Japan
- 7.4.5.1.1. Key market trends, growth factors and opportunities
- 7.4.5.1.2. Market size and forecast, by Type
- 7.4.5.1.3. Market size and forecast, by Model
- 7.4.5.1.4. Market size and forecast, by Setting
- 7.4.5.2. China
- 7.4.5.2.1. Key market trends, growth factors and opportunities
- 7.4.5.2.2. Market size and forecast, by Type
- 7.4.5.2.3. Market size and forecast, by Model
- 7.4.5.2.4. Market size and forecast, by Setting
- 7.4.5.3. India
- 7.4.5.3.1. Key market trends, growth factors and opportunities
- 7.4.5.3.2. Market size and forecast, by Type
- 7.4.5.3.3. Market size and forecast, by Model
- 7.4.5.3.4. Market size and forecast, by Setting
- 7.4.5.4. Australia
- 7.4.5.4.1. Key market trends, growth factors and opportunities
- 7.4.5.4.2. Market size and forecast, by Type
- 7.4.5.4.3. Market size and forecast, by Model
- 7.4.5.4.4. Market size and forecast, by Setting
- 7.4.5.5. South Korea
- 7.4.5.5.1. Key market trends, growth factors and opportunities
- 7.4.5.5.2. Market size and forecast, by Type
- 7.4.5.5.3. Market size and forecast, by Model
- 7.4.5.5.4. Market size and forecast, by Setting
- 7.4.5.6. Rest of Asia-Pacific
- 7.4.5.6.1. Key market trends, growth factors and opportunities
- 7.4.5.6.2. Market size and forecast, by Type
- 7.4.5.6.3. Market size and forecast, by Model
- 7.4.5.6.4. Market size and forecast, by Setting
- 7.5. LAMEA
- 7.5.1. Key trends and opportunities
- 7.5.2. Market size and forecast, by Type
- 7.5.2.1. LAMEA Therapeutic Advanced Clinical Decision Support Platforms Market by Setting
- 7.5.2.2. LAMEA Diagnostic Advanced Clinical Decision Support Platforms Market by Setting
- 7.5.3. Market size and forecast, by Model
- 7.5.4. Market size and forecast, by Setting
- 7.5.5. Market size and forecast, by country
- 7.5.5.1. Brazil
- 7.5.5.1.1. Key market trends, growth factors and opportunities
- 7.5.5.1.2. Market size and forecast, by Type
- 7.5.5.1.3. Market size and forecast, by Model
- 7.5.5.1.4. Market size and forecast, by Setting
- 7.5.5.2. Saudi Arabia
- 7.5.5.2.1. Key market trends, growth factors and opportunities
- 7.5.5.2.2. Market size and forecast, by Type
- 7.5.5.2.3. Market size and forecast, by Model
- 7.5.5.2.4. Market size and forecast, by Setting
- 7.5.5.3. South Africa
- 7.5.5.3.1. Key market trends, growth factors and opportunities
- 7.5.5.3.2. Market size and forecast, by Type
- 7.5.5.3.3. Market size and forecast, by Model
- 7.5.5.3.4. Market size and forecast, by Setting
- 7.5.5.4. Rest of LAMEA
- 7.5.5.4.1. Key market trends, growth factors and opportunities
- 7.5.5.4.2. Market size and forecast, by Type
- 7.5.5.4.3. Market size and forecast, by Model
- 7.5.5.4.4. Market size and forecast, by Setting
- CHAPTER 8: COMPETITIVE LANDSCAPE
- 8.1. Introduction
- 8.2. Top winning strategies
- 8.3. Product Mapping of Top 10 Player
- 8.4. Competitive Dashboard
- 8.5. Competitive Heatmap
- 8.6. Top player positioning, 2021
- CHAPTER 9: COMPANY PROFILES
- 9.1. IBM Watson Health
- 9.1.1. Company overview
- 9.1.2. Key Executives
- 9.1.3. Company snapshot
- 9.1.4. Operating business segments
- 9.1.5. Product portfolio
- 9.1.6. Business performance
- 9.1.7. Key strategic moves and developments
- 9.2. Meditech
- 9.2.1. Company overview
- 9.2.2. Key Executives
- 9.2.3. Company snapshot
- 9.2.4. Operating business segments
- 9.2.5. Product portfolio
- 9.3. NextGen Healthcare Inc.
- 9.3.1. Company overview
- 9.3.2. Key Executives
- 9.3.3. Company snapshot
- 9.3.4. Operating business segments
- 9.3.5. Product portfolio
- 9.3.6. Business performance
- 9.4. Siemens Healthineers
- 9.4.1. Company overview
- 9.4.2. Key Executives
- 9.4.3. Company snapshot
- 9.4.4. Operating business segments
- 9.4.5. Product portfolio
- 9.4.6. Business performance
- 9.4.7. Key strategic moves and developments
- 9.5. Veradigm Inc.
- 9.5.1. Company overview
- 9.5.2. Key Executives
- 9.5.3. Company snapshot
- 9.5.4. Operating business segments
- 9.5.5. Product portfolio
- 9.5.6. Business performance
- 9.5.7. Key strategic moves and developments
- 9.6. Wolters Kluwer
- 9.6.1. Company overview
- 9.6.2. Key Executives
- 9.6.3. Company snapshot
- 9.6.4. Operating business segments
- 9.6.5. Product portfolio
- 9.6.6. Business performance
- 9.6.7. Key strategic moves and developments
- 9.7. Zynx health
- 9.7.1. Company overview
- 9.7.2. Key Executives
- 9.7.3. Company snapshot
- 9.7.4. Operating business segments
- 9.7.5. Product portfolio
- 9.8. Oracle Corporation
- 9.8.1. Company overview
- 9.8.2. Key Executives
- 9.8.3. Company snapshot
- 9.8.4. Operating business segments
- 9.8.5. Product portfolio
- 9.8.6. Business performance
- 9.8.7. Key strategic moves and developments
- 9.9. Epic Systems Corporation
- 9.9.1. Company overview
- 9.9.2. Key Executives
- 9.9.3. Company snapshot
- 9.9.4. Operating business segments
- 9.9.5. Product portfolio
- 9.9.6. Key strategic moves and developments
- 9.10. Relx Group
- 9.10.1. Company overview
- 9.10.2. Key Executives
- 9.10.3. Company snapshot
- 9.10.4. Operating business segments
- 9.10.5. Product portfolio
- 9.10.6. Business performance
- 9.10.7. Key strategic moves and developments
- LIST OF TABLES
- TABLE 01. GLOBAL ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY TYPE, 2021-2031 ($MILLION)
- TABLE 02. ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET FOR THERAPEUTIC, BY REGION, 2021-2031 ($MILLION)
- TABLE 03. GLOBAL THERAPEUTIC ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY SETTING, 2021-2031 ($MILLION)
- TABLE 04. ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET FOR HOSPITALS, BY REGION, 2021-2031 ($MILLION)
- TABLE 05. ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET FOR AMBULATORY CARE, BY REGION, 2021-2031 ($MILLION)
- TABLE 06. ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET FOR DIAGNOSTIC, BY REGION, 2021-2031 ($MILLION)
- TABLE 07. GLOBAL DIAGNOSTIC ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY SETTING, 2021-2031 ($MILLION)
- TABLE 08. ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET FOR HOSPITALS, BY REGION, 2021-2031 ($MILLION)
- TABLE 09. ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET FOR AMBULATORY CARE, BY REGION, 2021-2031 ($MILLION)
- TABLE 10. GLOBAL ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY MODEL, 2021-2031 ($MILLION)
- TABLE 11. ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET FOR KNOWLEDGE BASED, BY REGION, 2021-2031 ($MILLION)
- TABLE 12. ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET FOR NON KNOWLEDGE BASED, BY REGION, 2021-2031 ($MILLION)
- TABLE 13. GLOBAL ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY SETTING, 2021-2031 ($MILLION)
- TABLE 14. ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET FOR HOSPITALS, BY REGION, 2021-2031 ($MILLION)
- TABLE 15. ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET FOR AMBULATORY CARE, BY REGION, 2021-2031 ($MILLION)
- TABLE 16. ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY REGION, 2021-2031 ($MILLION)
- TABLE 17. NORTH AMERICA ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY TYPE, 2021-2031 ($MILLION)
- TABLE 18. NORTH AMERICA THERAPEUTIC ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY SETTING, 2021-2031 ($MILLION)
- TABLE 19. NORTH AMERICA DIAGNOSTIC ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY SETTING, 2021-2031 ($MILLION)
- TABLE 20. NORTH AMERICA ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY MODEL, 2021-2031 ($MILLION)
- TABLE 21. NORTH AMERICA ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY SETTING, 2021-2031 ($MILLION)
- TABLE 22. NORTH AMERICA ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 23. U.S. ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY TYPE, 2021-2031 ($MILLION)
- TABLE 24. U.S. ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY MODEL, 2021-2031 ($MILLION)
- TABLE 25. U.S. ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY SETTING, 2021-2031 ($MILLION)
- TABLE 26. CANADA ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY TYPE, 2021-2031 ($MILLION)
- TABLE 27. CANADA ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY MODEL, 2021-2031 ($MILLION)
- TABLE 28. CANADA ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY SETTING, 2021-2031 ($MILLION)
- TABLE 29. MEXICO ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY TYPE, 2021-2031 ($MILLION)
- TABLE 30. MEXICO ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY MODEL, 2021-2031 ($MILLION)
- TABLE 31. MEXICO ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY SETTING, 2021-2031 ($MILLION)
- TABLE 32. EUROPE ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY TYPE, 2021-2031 ($MILLION)
- TABLE 33. EUROPE THERAPEUTIC ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY SETTING, 2021-2031 ($MILLION)
- TABLE 34. EUROPE DIAGNOSTIC ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY SETTING, 2021-2031 ($MILLION)
- TABLE 35. EUROPE ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY MODEL, 2021-2031 ($MILLION)
- TABLE 36. EUROPE ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY SETTING, 2021-2031 ($MILLION)
- TABLE 37. EUROPE ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 38. GERMANY ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY TYPE, 2021-2031 ($MILLION)
- TABLE 39. GERMANY ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY MODEL, 2021-2031 ($MILLION)
- TABLE 40. GERMANY ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY SETTING, 2021-2031 ($MILLION)
- TABLE 41. FRANCE ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY TYPE, 2021-2031 ($MILLION)
- TABLE 42. FRANCE ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY MODEL, 2021-2031 ($MILLION)
- TABLE 43. FRANCE ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY SETTING, 2021-2031 ($MILLION)
- TABLE 44. UK ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY TYPE, 2021-2031 ($MILLION)
- TABLE 45. UK ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY MODEL, 2021-2031 ($MILLION)
- TABLE 46. UK ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY SETTING, 2021-2031 ($MILLION)
- TABLE 47. ITALY ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY TYPE, 2021-2031 ($MILLION)
- TABLE 48. ITALY ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY MODEL, 2021-2031 ($MILLION)
- TABLE 49. ITALY ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY SETTING, 2021-2031 ($MILLION)
- TABLE 50. SPAIN ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY TYPE, 2021-2031 ($MILLION)
- TABLE 51. SPAIN ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY MODEL, 2021-2031 ($MILLION)
- TABLE 52. SPAIN ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY SETTING, 2021-2031 ($MILLION)
- TABLE 53. REST OF EUROPE ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY TYPE, 2021-2031 ($MILLION)
- TABLE 54. REST OF EUROPE ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY MODEL, 2021-2031 ($MILLION)
- TABLE 55. REST OF EUROPE ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY SETTING, 2021-2031 ($MILLION)
- TABLE 56. ASIA-PACIFIC ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY TYPE, 2021-2031 ($MILLION)
- TABLE 57. ASIA-PACIFIC THERAPEUTIC ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY SETTING, 2021-2031 ($MILLION)
- TABLE 58. ASIA-PACIFIC DIAGNOSTIC ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY SETTING, 2021-2031 ($MILLION)
- TABLE 59. ASIA-PACIFIC ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY MODEL, 2021-2031 ($MILLION)
- TABLE 60. ASIA-PACIFIC ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY SETTING, 2021-2031 ($MILLION)
- TABLE 61. ASIA-PACIFIC ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 62. JAPAN ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY TYPE, 2021-2031 ($MILLION)
- TABLE 63. JAPAN ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY MODEL, 2021-2031 ($MILLION)
- TABLE 64. JAPAN ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY SETTING, 2021-2031 ($MILLION)
- TABLE 65. CHINA ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY TYPE, 2021-2031 ($MILLION)
- TABLE 66. CHINA ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY MODEL, 2021-2031 ($MILLION)
- TABLE 67. CHINA ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY SETTING, 2021-2031 ($MILLION)
- TABLE 68. INDIA ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY TYPE, 2021-2031 ($MILLION)
- TABLE 69. INDIA ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY MODEL, 2021-2031 ($MILLION)
- TABLE 70. INDIA ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY SETTING, 2021-2031 ($MILLION)
- TABLE 71. AUSTRALIA ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY TYPE, 2021-2031 ($MILLION)
- TABLE 72. AUSTRALIA ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY MODEL, 2021-2031 ($MILLION)
- TABLE 73. AUSTRALIA ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY SETTING, 2021-2031 ($MILLION)
- TABLE 74. SOUTH KOREA ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY TYPE, 2021-2031 ($MILLION)
- TABLE 75. SOUTH KOREA ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY MODEL, 2021-2031 ($MILLION)
- TABLE 76. SOUTH KOREA ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY SETTING, 2021-2031 ($MILLION)
- TABLE 77. REST OF ASIA-PACIFIC ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY TYPE, 2021-2031 ($MILLION)
- TABLE 78. REST OF ASIA-PACIFIC ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY MODEL, 2021-2031 ($MILLION)
- TABLE 79. REST OF ASIA-PACIFIC ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY SETTING, 2021-2031 ($MILLION)
- TABLE 80. LAMEA ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY TYPE, 2021-2031 ($MILLION)
- TABLE 81. LAMEA THERAPEUTIC ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY SETTING, 2021-2031 ($MILLION)
- TABLE 82. LAMEA DIAGNOSTIC ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY SETTING, 2021-2031 ($MILLION)
- TABLE 83. LAMEA ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY MODEL, 2021-2031 ($MILLION)
- TABLE 84. LAMEA ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY SETTING, 2021-2031 ($MILLION)
- TABLE 85. LAMEA ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 86. BRAZIL ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY TYPE, 2021-2031 ($MILLION)
- TABLE 87. BRAZIL ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY MODEL, 2021-2031 ($MILLION)
- TABLE 88. BRAZIL ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY SETTING, 2021-2031 ($MILLION)
- TABLE 89. SAUDI ARABIA ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY TYPE, 2021-2031 ($MILLION)
- TABLE 90. SAUDI ARABIA ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY MODEL, 2021-2031 ($MILLION)
- TABLE 91. SAUDI ARABIA ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY SETTING, 2021-2031 ($MILLION)
- TABLE 92. SOUTH AFRICA ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY TYPE, 2021-2031 ($MILLION)
- TABLE 93. SOUTH AFRICA ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY MODEL, 2021-2031 ($MILLION)
- TABLE 94. SOUTH AFRICA ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY SETTING, 2021-2031 ($MILLION)
- TABLE 95. REST OF LAMEA ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY TYPE, 2021-2031 ($MILLION)
- TABLE 96. REST OF LAMEA ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY MODEL, 2021-2031 ($MILLION)
- TABLE 97. REST OF LAMEA ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY SETTING, 2021-2031 ($MILLION)
- TABLE 98. IBM WATSON HEALTH: KEY EXECUTIVES
- TABLE 99. IBM WATSON HEALTH: COMPANY SNAPSHOT
- TABLE 100. IBM WATSON HEALTH: PRODUCT SEGMENTS
- TABLE 101. IBM WATSON HEALTH: PRODUCT PORTFOLIO
- TABLE 102. IBM WATSON HEALTH: KEY STRATERGIES
- TABLE 103. MEDITECH: KEY EXECUTIVES
- TABLE 104. MEDITECH: COMPANY SNAPSHOT
- TABLE 105. MEDITECH: SERVICE SEGMENTS
- TABLE 106. MEDITECH: PRODUCT PORTFOLIO
- TABLE 107. NEXTGEN HEALTHCARE INC.: KEY EXECUTIVES
- TABLE 108. NEXTGEN HEALTHCARE INC.: COMPANY SNAPSHOT
- TABLE 109. NEXTGEN HEALTHCARE INC.: PRODUCT SEGMENTS
- TABLE 110. NEXTGEN HEALTHCARE INC.: PRODUCT PORTFOLIO
- TABLE 111. SIEMENS HEALTHINEERS: KEY EXECUTIVES
- TABLE 112. SIEMENS HEALTHINEERS: COMPANY SNAPSHOT
- TABLE 113. SIEMENS HEALTHINEERS: PRODUCT SEGMENTS
- TABLE 114. SIEMENS HEALTHINEERS: PRODUCT PORTFOLIO
- TABLE 115. SIEMENS HEALTHINEERS: KEY STRATERGIES
- TABLE 116. VERADIGM INC.: KEY EXECUTIVES
- TABLE 117. VERADIGM INC.: COMPANY SNAPSHOT
- TABLE 118. VERADIGM INC.: PRODUCT SEGMENTS
- TABLE 119. VERADIGM INC.: PRODUCT PORTFOLIO
- TABLE 120. VERADIGM INC.: KEY STRATERGIES
- TABLE 121. WOLTERS KLUWER: KEY EXECUTIVES
- TABLE 122. WOLTERS KLUWER: COMPANY SNAPSHOT
- TABLE 123. WOLTERS KLUWER: SERVICE SEGMENTS
- TABLE 124. WOLTERS KLUWER: PRODUCT PORTFOLIO
- TABLE 125. WOLTERS KLUWER: KEY STRATERGIES
- TABLE 126. ZYNX HEALTH: KEY EXECUTIVES
- TABLE 127. ZYNX HEALTH: COMPANY SNAPSHOT
- TABLE 128. ZYNX HEALTH: PRODUCT SEGMENTS
- TABLE 129. ZYNX HEALTH: PRODUCT PORTFOLIO
- TABLE 130. ORACLE CORPORATION: KEY EXECUTIVES
- TABLE 131. ORACLE CORPORATION: COMPANY SNAPSHOT
- TABLE 132. ORACLE CORPORATION: PRODUCT SEGMENTS
- TABLE 133. ORACLE CORPORATION: PRODUCT PORTFOLIO
- TABLE 134. ORACLE CORPORATION: KEY STRATERGIES
- TABLE 135. EPIC SYSTEMS CORPORATION: KEY EXECUTIVES
- TABLE 136. EPIC SYSTEMS CORPORATION: COMPANY SNAPSHOT
- TABLE 137. EPIC SYSTEMS CORPORATION: SERVICE SEGMENTS
- TABLE 138. EPIC SYSTEMS CORPORATION: PRODUCT PORTFOLIO
- TABLE 139. EPIC SYSTEMS CORPORATION: KEY STRATERGIES
- TABLE 140. RELX GROUP: KEY EXECUTIVES
- TABLE 141. RELX GROUP: COMPANY SNAPSHOT
- TABLE 142. RELX GROUP: SERVICE SEGMENTS
- TABLE 143. RELX GROUP: PRODUCT PORTFOLIO
- TABLE 144. RELX GROUP: KEY STRATERGIES
- LIST OF FIGURES
- FIGURE 01. ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, 2021-2031
- FIGURE 02. SEGMENTATION OF ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, 2021-2031
- FIGURE 03. TOP INVESTMENT POCKETS IN ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET (2022-2031)
- FIGURE 04. LOW BARGAINING POWER OF SUPPLIERS
- FIGURE 05. LOW BARGAINING POWER OF BUYERS
- FIGURE 06. LOW THREAT OF SUBSTITUTES
- FIGURE 07. LOW THREAT OF NEW ENTRANTS
- FIGURE 08. LOW INTENSITY OF RIVALRY
- FIGURE 09. DRIVERS, RESTRAINTS AND OPPORTUNITIES: GLOBALADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET
- FIGURE 10. ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY TYPE, 2021(%)
- FIGURE 11. COMPARATIVE SHARE ANALYSIS OF ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET FOR THERAPEUTIC, BY COUNTRY 2021-2031(%)
- FIGURE 12. COMPARATIVE SHARE ANALYSIS OF ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET FOR DIAGNOSTIC, BY COUNTRY 2021-2031(%)
- FIGURE 13. ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY MODEL, 2021(%)
- FIGURE 14. COMPARATIVE SHARE ANALYSIS OF ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET FOR KNOWLEDGE BASED, BY COUNTRY 2021-2031(%)
- FIGURE 15. COMPARATIVE SHARE ANALYSIS OF ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET FOR NON KNOWLEDGE BASED, BY COUNTRY 2021-2031(%)
- FIGURE 16. ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, BY SETTING, 2021(%)
- FIGURE 17. COMPARATIVE SHARE ANALYSIS OF ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET FOR HOSPITALS, BY COUNTRY 2021-2031(%)
- FIGURE 18. COMPARATIVE SHARE ANALYSIS OF ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET FOR AMBULATORY CARE, BY COUNTRY 2021-2031(%)
- FIGURE 19. ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET BY REGION, 2021
- FIGURE 20. U.S. ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, 2021-2031 ($MILLION)
- FIGURE 21. CANADA ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, 2021-2031 ($MILLION)
- FIGURE 22. MEXICO ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, 2021-2031 ($MILLION)
- FIGURE 23. GERMANY ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, 2021-2031 ($MILLION)
- FIGURE 24. FRANCE ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, 2021-2031 ($MILLION)
- FIGURE 25. UK ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, 2021-2031 ($MILLION)
- FIGURE 26. ITALY ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, 2021-2031 ($MILLION)
- FIGURE 27. SPAIN ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, 2021-2031 ($MILLION)
- FIGURE 28. REST OF EUROPE ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, 2021-2031 ($MILLION)
- FIGURE 29. JAPAN ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, 2021-2031 ($MILLION)
- FIGURE 30. CHINA ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, 2021-2031 ($MILLION)
- FIGURE 31. INDIA ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, 2021-2031 ($MILLION)
- FIGURE 32. AUSTRALIA ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, 2021-2031 ($MILLION)
- FIGURE 33. SOUTH KOREA ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, 2021-2031 ($MILLION)
- FIGURE 34. REST OF ASIA-PACIFIC ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, 2021-2031 ($MILLION)
- FIGURE 35. BRAZIL ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, 2021-2031 ($MILLION)
- FIGURE 36. SAUDI ARABIA ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, 2021-2031 ($MILLION)
- FIGURE 37. SOUTH AFRICA ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, 2021-2031 ($MILLION)
- FIGURE 38. REST OF LAMEA ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET, 2021-2031 ($MILLION)
- FIGURE 39. TOP WINNING STRATEGIES, BY YEAR
- FIGURE 40. TOP WINNING STRATEGIES, BY DEVELOPMENT
- FIGURE 41. TOP WINNING STRATEGIES, BY COMPANY
- FIGURE 42. PRODUCT MAPPING OF TOP 10 PLAYERS
- FIGURE 43. COMPETITIVE DASHBOARD
- FIGURE 44. COMPETITIVE HEATMAP: ADVANCED CLINICAL DECISION SUPPORT PLATFORMS MARKET
- FIGURE 45. TOP PLAYER POSITIONING, 2021
- FIGURE 46. IBM WATSON HEALTH: NET REVENUE, 2019-2021 ($MILLION)
- FIGURE 47. IBM WATSON HEALTH: REVENUE SHARE BY SEGMENT, 2021 (%)
- FIGURE 48. IBM WATSON HEALTH: REVENUE SHARE BY REGION, 2021 (%)
- FIGURE 49. NEXTGEN HEALTHCARE INC.: NET REVENUE, 2019-2021 ($MILLION)
- FIGURE 50. NEXTGEN HEALTHCARE INC.: REVENUE SHARE BY SEGMENT, 2021 (%)
- FIGURE 51. SIEMENS HEALTHINEERS: NET REVENUE, 2019-2021 ($MILLION)
- FIGURE 52. SIEMENS HEALTHINEERS: REVENUE SHARE BY SEGMENT, 2021 (%)
- FIGURE 53. SIEMENS HEALTHINEERS: REVENUE SHARE BY REGION, 2021 (%)
- FIGURE 54. VERADIGM INC.: NET REVENUE, 2019-2021 ($MILLION)
- FIGURE 55. VERADIGM INC.: REVENUE SHARE BY SEGMENT, 2021 (%)
- FIGURE 56. VERADIGM INC.: REVENUE SHARE BY REGION, 2021 (%)
- FIGURE 57. WOLTERS KLUWER: NET REVENUE, 2019-2021 ($MILLION)
- FIGURE 58. WOLTERS KLUWER: REVENUE SHARE BY REGION, 2021 (%)
- FIGURE 59. ORACLE CORPORATION: NET REVENUE, 2020-2022 ($MILLION)
- FIGURE 60. ORACLE CORPORATION: RESEARCH & DEVELOPMENT EXPENDITURE, 2020-2022
- FIGURE 61. ORACLE CORPORATION: REVENUE SHARE BY SEGMENT, 2022 (%)
- FIGURE 62. ORACLE CORPORATION: REVENUE SHARE BY REGION, 2022 (%)
- FIGURE 63. RELX GROUP: NET REVENUE, 2019-2021 ($MILLION)
- FIGURE 64. RELX GROUP: REVENUE SHARE BY SEGMENT, 2021 (%)
- FIGURE 65. RELX GROUP: REVENUE SHARE BY REGION, 2021 (%)
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook